Loading…
Underlying
Underlying Price
$8.36
Type
Put
Strike
8.5
Expiration
Nov 27, 2026
DTE
38d
Moneyness
ITM
Intrinsic
$0.14
IBRX 8.5 Put Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 3d | $0.11 | +22.22% | 5 | 355 |
| Oct 30, 2026 | 10d | $0.35 | +75.00% | 33 | 1,052 |
| Nov 6, 2026 | 17d | $0.40 | +21.21% | 115 | 176 |
| Nov 13, 2026 | 24d | $0.45 | -6.25% | 5 | 27 |
| Nov 27, 2026 | 38d | $0.80 | +0.00% | 4 | 3 |
IBRX Profile
immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.